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ABSTRACT
This paper presents opto-physiological (OP) modeling and its application in cardiovascular
assessment techniques based on photoplethysmography (PPG). Existing contact point
measurement techniques, i.e., pulse oximetry probes, are compared with the next generation non-
contact and imaging implementations, i.e., non-contact reflection and camera-based PPG. The
further development of effective physiological monitoring techniques relies on novel approaches
to OP modeling that can better inform the design and development of sensing hardware and
applicable signal processing procedures. With the help of finite-element optical simulation,
fundamental research into OP modeling of photoplethysmography is being exploited towards the
development of engineering solutions for practical biomedical systems. This paper reviews a
body of research comprising two OP models that have led to significant progress in the design of
transmission mode pulse oximetry probes, and approaches to 3D blood perfusion mapping for the
interpretation of cardiovascular performance.
Keywords: opto-physiological modeling, pulse oximetry, imaging photoplethysmography
(iPPG), region of interest (ROI), signal and image processing, cardiovascular assessment
1. INTRODUCTION
Photoplethysmography (PPG) is an optical technique for non-invasive measurement of
changes in blood volume, indirectly based on variations in light intensity passing
through, or reflected from, skin tissue, through the use of an illumination source and a
photodetector [1]. Variations in the detected output originate from the pulsation of
arterial blood within the peripheral vasculature as stimulated by the quasi-periodic
cardiac cycle [2].
PPG is ideally suited for the assessment of peripheral circulation in medical and
biomedical monitoring setups [5, 6]. Prior art defines that PPG signals are composed of
two key components [7]: a pulsatile part (AC component) of total absorbance from both
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arterial blood and venous blood, and a quasi-static non-pulsatile component (DC
component) attributed to tissue and venous blood. The AC component of the PPG signal
has been used to assess peripheral vascular compliance [8], and the DC component of
the PPG signal can be affected by respiration, the sympathetic nervous system and
thermoregulation [3]. The normalized pulse wave using both AC and DC components
could indicate peripheral blood volume changes more reliably [10].
Among PPG applications, pulse oximetry—the determination of arterial oxygen
saturation—is the most widespread, thanks to its ability to alert the clinician of the
presence of hypoxemia in real time [11]. A non-invasive method of monitoring
peripheral venous oxygen saturation (SxvO2) with an artificial venous pulse at the
finger was successfully developed to serve as an adjunct/early warning indicator of
imbalances in oxygen supply and demand [12]. Pulse oximetry is an important tool to
evaluate and monitor pulmonary diseases, but the current knowledge of arterial oxygen
saturation (SpO2) values provides a limited description of the distribution of low pulse
oximetry values in a general adult population and their association with certain
predictors [13]. Pulse oximetry data such as saturation of peripheral oxygen (SpO2) and
pulse rate are vital signals for early diagnosis of cardiovascular disease, and such a
system should be equipped with communication capabilities to achieve remote
monitoring and management [14].
1.1. Limitations of PPG Technology
Despite their proven usefulness, oximeters derived from photoplethysmography have a
number of factors that lead to inaccurate readings and limit their applicability. The
contact PPG (cPPG) probes most commonly found in commercially available pulse
oximeters use only two wavelengths—an arrangement that assumes the presence of
only hemoglobin and oxyhemoglobin in the blood. The presence of other species of
hemoglobin in blood, i.e. carboxyhemoglobin and methemoglobin [15], and other
factors, i.e., heavy skin pigmentation [16], have been proven to lead to measurement
errors in pulse oximetry. The following are potential areas of research to increase the
reliability and applicability of the oximeter technology:
(1) Commercial pulse oximeters convert the ratio of normalized pulsatile components
into an equivalent arterial oxygen saturation by means of a linear or bilinear
relationship look-up table which is determined by comparison of oximeter
readings with invasive blood gas measurements [17]. This calibration is generally
applied with oxygen saturation values above 70% due to serious health risks
encountered by test subjects for saturations bel ow this point. Even though this
factor does not affect the performance of oximeters in their primary function of
warning clinicians of an unhealthy condition, it does limit their applicability, for
instance, in the assessment of fetal wellbeing [18].
(2) A common source of PPG signal corruption is the inadvertent measurement of
ambient light and voluntary or involuntary movement of the patient [19]. Ambient
light artifact is generally not an issue since oximeters are designed to isolate its
contribution to the signal, and the effect can be further reduced by covering the
probe with an opaque shield when necessary [20]. Motion artifact, however, is a
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complex issue due to its contribution to the PPG signal being several orders of
magnitude larger than that of the arterial pulsations, and to the spectral and
temporal dependence between the arterial pulsations and the motion artifacts [21].
(3) In cases of low perfusion such as in critically ill patients, the low signal-to-noise
ratio (SNR) encountered under a lack of a strong pulsatile PPG signal component
leads to inaccurate readings [22]. This poses a serious drawback, as an adequate
knowledge of a patient’s oxygenation is especially important under these
circumstances.
(4) Skin pigmentation and nail polish absorb red and infrared (IR) light at differing
degrees, an effect which can reduce the SNR and cause minor offsets in oximeter
readings [23]. Interference from certain substances in blood, however, can severely
compromise the reliability of saturation readings. An increased level of
dyshemoglobins in blood, such as carboxyhemoglobin and methemoglobin, are
known to cause inaccurate oximetry readings due to the fact that commercial device
calibration is performed under healthy volunteers with normal levels of 
these dyshemoglobins [24]. Intravenous dyes absorb light from the two wavelengths
at different degrees, and thus manifest as a change in the absorption characteristics
of the affected blood volume, rendering device calibration curves ineffective [20].
1.2. Progress in PPG Technology
Motivated by general trends towards remote sensing and the desire to reduce physical
restrictions and cabling associated with patient monitoring, research efforts are targeting
non-contact camera-based PPG [25, 26, 27]. An imaging PPG (iPPG) system can result
in an alternative functional imaging solution to clinical situations that are currently
addressed utilizing magnetic resonance imaging (MRI) and laser Doppler perfusion
imaging (LDPI). This technique brings new insights by providing hemodynamic
imaging and mapping capabilities. The functionality of camera-based iPPG has been
well demonstrated through the visualization of blood perfusion [27, 28, 29], where the
simultaneous capture of PPG waveforms from a region of interest on the extremities
under illumination at two wavelengths (660 nm and 880 nm) was achieved. The 3-D
mapping of skin blood microcirculation [28] was constructed based upon the arterial
pulsation extracted from the iPPG signals, and a previous study shows the comparability
of iPPG with conventional cPPG and the capability of obtaining good quality PPG
pulsatile signals from a human face [29]. The recent proliferation of mobile applications
is bringing about an inevitable trend in the collection of physiological parameters for
personal healthcare [30, 31, 32, 33]. In a growing list of personal physiological
monitoring apps available online for the iPhone, iPad, and Android devices, ‘Instant
Heart Rate’ by Azumio [34] and ‘Vital Signs Camera’ by Philips [35] have attracted
significant public interest despite not being intended for clinical or diagnostic use.
The success of solutions to engineering challenges in PPG technology depends
heavily on the validity of the assumptions employed to interpret the PPG signals. In OP
models based on the Beer-Lambert equation, the measuring site is treated as a blood-
filled cuvette with no scattering effects and the light sources are assumed to be
monochromatic [36, 37]. With the increasing availability and accuracy of tissue optical
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properties [38, 39, 40], the use of numerical solutions of light propagation in human
tissue are providing increasingly valuable insights into such mechanisms. Motion
artifact is one of key challenges in PPG-based biomedical monitoring techniques, and
the reduction of this phenomenon has been investigated through different approaches
[41, 42] to improve the SNR and to obtain a more robust data readout for more reliable
clinical assessment.
The long-term goal of the body of research presented in this paper is to validate
increasingly accurate and applicable models of opto-physiological systems. This paper
presents three aspects of the development of effective OP models: 1) modeling of
transmission- and reflection-mode PPG, 2) empirical studies and their signal and image
processing procedures, and 3) the applicability of OP models in physiological
monitoring systems.
2. MODELING AND SIMULATION
The concepts underlying OP modeling are considered in the context of transmission-
and reflection-mode PPG. The common physical assumption implicit in PPG is that
changes in measured light intensity are due to changes in blood volume. Light is
transmitted through the anatomy of the subject, resulting in a measured intensity that
depends upon the wavelength and intensity of source in addition to the optical
interaction with the subject. This interaction can be expressed using the Beer-Lambert
law [9], which defines the light transmittance through a medium such as blood in terms
of its molar coefficient of absorption and the length of the optical path.
(1)
where l is the optical path length, µ is the extinction coefficient, I0 is the source
intensity, and I(λ) is the received intensity for a light source of wavelength λ. Whilst the
physical applicability of the Beer-Lambert law is questionable [3], it has been shown
that this approximation to the complex optical interactions that occur in tissue can give
a good first order solution [4].
The radiative transfer equation (RTE) [43] provides a highly accurate mathematical
description of the interaction of light with a physical system (Figure 1). It incorporates
anisotropic scattering, which more accurately reflects the tissue characteristics;
however, the increase in mathematical complexity from the use of complicated tissue
models makes the application of this model extremely difficult [44, 45].
The PPG formulation of the Beer-Lambert law (eqn. 1) can be modified according
to alternate approaches to the modeling of absorption, scattering and optical path
length in living tissue. The models presented below are a progression from the
standard Beer-Lambert Model used for PPG in pulse oximetry, allowing the inclusion
of the fast growing tissue optics data [46]. By providing compatibility with
increasingly popular Monte-Carlo solutions to the mathematically rigorous RTE for
optical propagation in tissue, these models facilitate the discovery of relationships
between the optical properties and the physiological information of the measuring site.
I I l( ) exp[ ( ) ]λ µ λ= −0
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2.1. Beyond the Standard Beer-Lambert Model for PPG
Light travelling through highly scattering tissue undergoes diffusion and, on average,
travels a distance proportionally greater than the source-detector separation according
to the degree of scattering in the medium. Delpy et al. [47, 48] proposed an elegant and
physically significant approach to the inclusion of scattering in a Beer-Lambert
formulation. Assuming that the absorption is proportionally increased according to the
effective path length increase due to scattering, it is possible to model the attenuation
as a factor of absorption and mean optical path length:
(2)
where µa is the absorption coefficient, and the mean path length L is a function of the
reduced scattering coefficient µ′s Both of these coefficients are fundamental optical
properties commonly used in tissue optics studies and are compatible with the
mathematically rigorous RTE used in Monte Carlo simulations of light propagation in
tissue.
The standard Beer-Lambert formulation considers the instantaneous absorption
of light in a measuring site. It is well known that in a real scenario, and the
I I La( ) exp[ ( ) ]λ µ λ= × −0
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Figure 1. Diagram of a general two-layer tissue model compatible with the
radiative transfer equation, showing layer thicknesses (dn), absorption
coefficients (µa), scattering coefficients (µs), anisotropy factors (gn) and
refractive indices (nn).
measuring site is dynamic, thereby yielding a received intensity that varies with
time. Hence formulating blood volume changes with respect to time becomes
durable. Treating the measuring site as a geometrically static structure and the
absorption coefficient as a dynamic optical property µa(t) with a static component
µa(static). yields:
(3)
where ρ(ωt) is the function of a normalized PPG waveform and σ is a coefficient of
pulsatility.
The dynamic component of the absorption can be attributed to the fractional change
in blood volume arising from arterial blood pulsations, and the static component can be
attributed to the combination of the non-pulsatile fraction of arterial blood volume and
the venous blood. In this case, venous blood is treated as a static component of
absorption and assuming the case where measurements are taken from a subject at rest.
The inclusion of time variance in the model can be achieved in a manner more
representative of the physical system (real tissue) through the use of a time-varying
mean path length:
(4)
The mean path length Lρ (ωt) can be broken down into static and dynamic
components, corresponding to the optical path lengths of static tissue and blood,
respectively:
(5)
Observation of the measured intensity in both transmission and reflection modes
indicates that the pulsatile component accounts for only a very small proportion of the
total intensity [49]. This results from the fact that a skin vascular bed contains only a
small amount of blood (2–5%) [50], which itself experiences only a small volumetric
change (around 5%) [51] with the cardio-vascular pulse wave.
2.2. Opto-Physiological Modeling of Transmission-Mode PPG
An effective OP model for transmission-mode PPG on a human finger was proposed
and verified through a designated protocol [52], based on the use of mean path length
to account for scattering effects [47, 48]. The model considers a set of physiologically
significant layers on the measuring site and their corresponding absorption (µa),
scattering (represented as detector-dependent mean path lengths L(det)) and pulsatility
coefficients (σ ), as a function of wavelength (λ), layer (i), longitudinal (x) and
circumferential (θ) positions:
I I La a( ) exp ( ) (( ) ( )λ µ λ µ= × − +0 static static blood λ ρ ω) ( )L tdynamic { }
I I L ta( ) exp[ ( ) ( )]λ µ λ ρ ω= × −0
µ λ µ λ σρ ωa at t( , ) ( ) [ ( )]( )= × +static 1
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(6)
The data conversion algorithms map the distribution of ray exit points in 3D
space (x, y, z) to a cylindrical coordinate system, as would be seen on a flattened
outer skin surface (x, y). This is achieved by generating a central axis in 3D
coordinates along the center of the finger model and converting the cross-sectional
coordinates into equivalent angles, resulting in a surface plot of position along
length in mm versus position along circumference in degrees (Figure 2). Surface
analysis algorithms split these ray surfaces into square intensity buckets (virtual
detectors) of arbitrary size and collect the total intensity of all rays within each
bucket, thus producing an intensity distribution surface. The static and dynamic
intensity surfaces are defined as
(7)
where It (x,y) is the intensity at pixel position (x, y), I (x, y) is the total intensity of
the bucket centered at pixel position (x, y), xa = x0 – d, ya = y0 – d, xb = x0 + d and 
yb = y0 + d, where (x0, y0) is the position on the flattened finger surface, and d is the
square bucket half-size. Eqn. 7 is used to derive the ratio of ratios R as a function of
surface position:
I x y I x yt
x x y y
x x y y
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b b
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Figure 2. Outer skin model with central finger axis highlighted (left), and resultant
plot after conversion of transmitted ray coordinates from 3D to
cylindrical (2D) coordinates (right). The light source position is marked
by an asterisk (*).
(8)
2.3. Opto-Physiological Modeling for Reflection-Mode PPG
To model reflection-mode PPG, the layered absorption µa as a function of wavelength
λ and layer k, and the detector-dependent pulsatile mean path length L(AC) as a function
of layer k and time t are considered for an arbitrary detector position, where the dynamic
component I(AC)(k), representing specific layer blood perfusion can be derived as:
(9)
where I(AC) is the pulsatile component of the imaging PPG signal acquired from the
arbitrary detector position. By considering all detector positions over the designated
tissue, 3-D mapping of segment blood perfusion can be achieved. Consequently, the
static blood perfusion component of a specific layer k can be derived with its weight
w(DC)(k) and the total static component as:
where µa(DC) is the wavelength-dependent absorption coefficient of static component
of tissue in mm–1, and L(DC) is the static component of mean path length (MPL) in mm.
Similarly, the perfusion I (AC) of a specific layer k can be expressed as the product of the
total perfusion and w(AC)(k):
(11)
where µa(AC) is the wavelength-dependent absorption coefficient of arterial blood in
mm–1, and, L(AC) is the dynamic component of mean path length in mm.
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2.4. Monte Carlo Simulation
A Monte Carlo (MC) simulation platform was developed for this work for the purpose
of providing a detailed description of the light propagation in a multi-layered tissue with
dynamic blood volume changes. The platform utilizes two commercially available
software packages. OptiCAD (OptiCAD Co., USA) comprises an MC ray-tracing
engine where the coordinates of traced ray vertices is generated, thereby making the
calculation of mean path length a straightforward process. MATLAB (Mathworks Co.,
USA) was chosen as a development language for data processing algorithms, and for
preparation of the 3D models used in simulation. Post data processing was performed
in MATLAB through the use of custom algorithms specific to the MC ray trace outputs.
In the mathematical tissue models presented in the previous section and in the
corresponding virtual models used in the simulation, the individual layers are assumed
to be homogeneous, and each layer is characterized by a bulk absorption coefficient µa,
scattering coefficient µs, anisotropy factor g and refractive index n. Contrary to this
assumption, the layers that make up tissue are neither homogeneous nor well-defined
and planar. Nonetheless, results of a previous study [53] indicate that the macroscopic
optical properties of whole tissue samples and tissue homogenates are similar.
The anisotropy factor g was set to 0.8 [44]. Although certain components of the
tissue volume such as collagen [54] and red blood cells [55] are more forward-
scattering, the value of 0.8 is more representative of overall dermal scattering. The
refractive index for all the layers was set to be 1.4 based upon the results of a relevant
study [56]. It should be noted that the model layer interfaces are artificial; the actual
structural interfaces in tissue (e.g., vessel walls) are at a finer level of detail than the
model represents. The simplifying assumptions made here are similar to those made in
other studies [41, 44, 57].
In blood perfused layers, the absorption coefficients of dermis and other highly
vascularised tissues in the near infrared spectral region depend on the blood content. Also,
the scattering in the dermis and in the sub-dermal tissues dominates absorption [58]. The
structures that contribute most to scattering in skin are collagen fibre bundles and red
blood cells, which cause highly forward-directed scattering [59]. The wavelength-
dependent optical properties of blood and tissue from literature [38, 39, 45, 57] are listed
in Table 1.
The total blood fraction (nominal 5%) is the mean concentration of blood in the total
tissue volume during the diastolic state. Layer thickness d(k), and blood fraction f(k) for
each layer in the diastolic state with nominal total blood fraction of 5% [51] is listed in
Table 2.
The absorption and scattering coefficients of the virtual skin tissue model were
computed as the combination of the coefficients of whole blood and bloodless tissue
weighted by their respective volume fractions:
(12)
where fblood is the total blood volume fraction, µbloodless is the absorption or scattering
coefficient of bloodless tissue in mm–1, and µblood is the absorption or scattering
coefficient of whole blood in mm–1.
µ µ µ= − × + ×( )1 f fblood bloodless blood blood
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Since each layer was assumed to be of uniform thickness, its volume was expressed
by its thicknesses alone. The pulsatile fraction is the fraction of the total tissue volume
displaced by the arterial pulse. A nominal diastolic blood fraction fblood was 5% with
nominal pulsatile fraction fpulse taken as 0.25% [51]. The pulsatile blood fraction was
applied uniformly to all perfused layers:
(13)f k d k
d
fpulse ( ) ( )=



× pulse
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Table 1. Optical properties of blood and bloodless tissue at 650 nm and
870 nm illumination
Var. Meaning 650 nm 870 nm
µa,bloodless (mm–1) absorption, bloodless tissue 0.0285 0.0245
µa,blood (mm–1) absorption, blood 0.397 0.583
µs,bloodless (mm–1) scattering, bloodless tissue 7.150 4.450
µs,blood (mm–1) scattering, blood 161.374 106.888
Table 2. Layer thickness d(k) and blood fraction f(k) for each layer in the
non-pulsatile state
k Layer name d (mm) f (%)
1 Epidermis 0.06 0
2 Dermis 0.2 0
3 Dermis Plexus Superficialis 0.2 5.56
4 Dermis 0.8 4.17
5 Dermis Plexus Profundus 0.6 20.4
6 Hypodermis 8.0 4.17
Table 3. Optical properties of each tissue layer for 870 nm illumination source
Layer (k) µa,non-pulsatile µ s,non-pulsatile µ a,pulsatile µ s,pulsatile
(mm–1) (mm–1) (mm–1) (µ–1)
Epidermis (1) 0.02450 4.4500 0.02450 4.4500
Dermis (2) 0.02450 4.4500 0.02450 4.4500
Dermis Plexus superficialis (3) 0.05556 10.1455 0.05559 10.1507
Dermis (4) 0.04779 8.7217 0.04791 8.7424
Dermis Plexus Profundus (5) 0.1383 25.3166 0.13840 25.3321
Hypodermis (6) 0.04779 8.7217 0.04892 8.9294
where fpluse is the overall pulse blood fraction of the tissue, fpluse(k) is the pulse blood
fraction of layer k, d(k) is the thickness of layer k in mm, and d is the total thickness
in mm.
In considering tissue with dynamic blood volume changes, the arterial pulsation was
simulated by adding the pulsatile blood into the non-pulsatile tissue and thus changing
the volume fraction of each component in tissue. The scattering and absorption
properties of tissue are changed in the non-pulsatile and pulsatile stages by linear
combination of the coefficients of each component weighted by its respective fraction.
Consequently, values for detector-specific mean path lengths, L(det)(static) and
L(det)(dynamic), were calculated based upon the tissue models with pulsatile and non-
pulsatile optical properties, respectively.
3. EMPIRICAL STUDIES
The experiments of transmission-mode and reflection-mode implementations of PPG
were carried out to investigate transmission- and reflection-mode OP models. These
experiments represent the first steps towards the validation of opto-physiological
models developed and simulated in section 2.
The processing pipeline for a standard PPG system can be divided into two stages,
namely the main and post-processing stages (Figure 3, left). The pipeline of a typical
iPPG system can be said to comprise an additional pre-processing stage, involving the
extraction of an array of meaningful PPG signals from the images captured by the
system (Figure 3, right).
3.1. Effective Signal and Image Processing Procedures
The pre-processing stage of an iPPG system involves the extraction of one or more PPG
signals from a sequence of images. To extract a signal from raw iPPG data, the average
value of pixels within an arbitrary region of interest (ROI) is taken from each frame.
Pre-processing also comprises an optional image stabilization process that is performed
prior to ROI signal extraction.
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Measurement of signal components
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Image stabilisation, signal extraction (ROI)
Measurement of signal components
Calculation, segmentation, physiogical maps
Display Display
Calculation of physiological parameters
Figure 3. Processing pipelines for point- and imaging-measurement PPG systems.
The main processing stage involves the measurement of static (tissue), quasi-static
(breathing) and dynamic (heart) components of PPG signals. For a point measurement
system, i.e., pulse oximetry probe, the number of signals passed to the main process is
typically a function of the number of illumination wavelengths, whereas for an iPPG
system, the number of signals is typically the product of the number of wavelengths and
ROI. The main processing stage employs time (e.g., filtering), frequency (e.g., spectral
peak detection), or joint time-frequency domain (e.g., Time-Frequency Representation)
techniques to measure PPG signal components.
- Filtering is used to separate the tissue, breathing and cardiac components of the
signal according to their frequency bands, where the DC amplitude is the tissue
component, the breathing component is typically less than 0.5 Hz, and the heart
(AC) component typically spans the 1–5 Hz range [60, 61]. Filtering is performed
on all raw PPG signals in this study.
- Once separated, the amplitudes of these components are readily accessible, and
the instantaneous frequencies of the non-static (breathing and heart) components
can be attained by measuring the time elapsed between adjacent peaks or troughs.
The peak-to-peak intensity of the AC components from filtered PPG signals can
be determined by taking the difference between the amplitudes of adjacent peaks
and troughs in the AC component.
- Reliant on the Fast Fourier Transform (FFT) algorithm, the conversion of raw
signal data into the frequency domain allows the measurement of amplitudes
and frequencies of PPG signal components via straightforward identification of
peaks in the resultant frequency spectrum. The fidelity of peaks in its frequency
spectrum is highly sensitive to both the sample rate of the signal and the length
of the signal segment (number of samples) used in the FFT, thus posing an
inherent tradeoff between temporal and spectral characterization of the PPG
data. An increased characterization of lower frequencies requires a greater
number of samples in the FFT, and since the vast majority of energy in a PPG
signal is located close to DC, the temporal/spectral tradeoff is aggravated.
The post-processing stage comprises the calculation of application-specific
physiological parameters using temporal and/or spectral data, and consists of operations
such as statistical calculations and unit conversions (scaling and offsetting) of the
measurements acquired in the previous stage. Physiological parameters that are
commonly calculated include heart rate (HR), respiration rate (RR) and pulse oximetry
(SO2). HR and RR are determined by taking the acquired frequency information (in Hz)
and resolving to corresponding values of beats and breaths per minute, respectively. The
determination of HR involves taking the time elapsed of the samples between two
adjacent peaks in the AC component of the PPG signal, dividing by the sampling rate
of the signal (samples/second), and multiplying by 60 to give the instantaneous heart
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rate in beats per minute. Pulse oximetry requires PPG signals that are simultaneously
acquired under at least two distinct wavelengths of illumination and involves
calculating the ratio of the amplitudes of the cardiac components to the corresponding
tissue components (also a relative measure of perfusion), calculating the ratio of these
normalized cardiac components (ratio of ratios) and acquiring the SO2 value
corresponding to that ratio from a calibration curve. In an iPPG system, the
physiological parameters calculated in this process are spatially defined in the 2-D
plane corresponding to the tissue surface being imaged. At this stage, it is therefore
common to generate a 2-D map of the physiological parameters. Furthermore, a multi-
layered tissue model can be applied at this stage, yielding a 3-D map of the layered
dynamic blood perfusion.
In an offline system, PPG information is readily available and can be processed with
no performance restrictions. For point measurement techniques, the dynamic (AC)
component of the signal is generally obtained by band-pass filtering, and the static (DC)
component of the static volume is obtained through low-pass filtering, e.g., 10th order
Butterworth [60]; the AC component corresponds to I(λ) as per eqn. 5, which is
obtained by applying a band-pass filter on the signal. In the case of imaging, ROI can
be arbitrarily chosen to investigate spatial variations in blood perfusion. In the
experiments detailed in this section, the common procedure used for the processing of
PPG signals involves the removal of the DC component from the captured PPG
waveform, leaving a typical PPG AC pulsatile signal which contains both HR and RR
components. These components can be measured in the time domain via band-pass
separation, or in the frequency domain via identification of peaks corresponding to each
component.
3.2. Validation of a Monte Carlo Platform for Opto-Physiological Modeling
An accurate virtual 3D anatomical model (Zygote Media Group, USA) of a male adult
finger was used to numerically solve the RTE for the case of a point source LED light
at 633 nm and 850 nm [63], placed near the standard position found in commercial
probes. The simulation results were processed using eqn. 6 to distinguish localized light
intensities that vary due to the cardiovascular cycle from those that are static, thus
providing a means to construct static and dynamic intensity distributions mapped to the
surface of the finger. Sensor responses were generated by scanning a square bucket of
arbitrary size in 0.1 mm increment from –1 to 1 mm longitudinally and from 0 to 360°
circumferentially.
For validation of Monte Carlo simulation results, a CMOS camera (Mightex, USA)
was mounted on a rotating platform that allowed the camera to maintain a constant
distance and alignment with respect to the subject’s finger (Figure 4) [52]. Sets of
frames were captured at each position between 90° and 270° in 9° increment (a total of
21 positions), where 180° is the standard transmittance mode sensor position with
respect to the light source. For each position, two sets of 200 frames were captured at
40 fps in immediate succession, i.e., for both red and infrared illumination. For each of
the sets, the mean peak-to-peak intensity and mean intensity was determined from
windows of size 10 × 10 pixels (1 pixel = 0.156 mm2), resulting in two additional
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frames representing the AC and DC intensity distributions of that set. Finally, the AC
and DC frames were trimmed and concatenated to form continuous intensity
distributions from 90° to 270°. The Loughborough University Ethics Committee
approved the protocol for this empirical study.
Figure 5 shows that the ratio of ratios in the range 120°–230° is stable with a
variation of ± 0.1, showing peaks corresponding to positions of blood vessels. The
drops at positions closest to the light source reflect the loss of dynamic signals due to
saturation of the red channel. A positive correlation can be seen between corresponding
signals at different wavelengths, and a negative correlation can be seen between Quasi-
DC and AC components for positions closest to the light source, i.e., 90° and 270°.
A study was performed on this validation platform [52], in which the fingers of 10
subjects were mapped and the resultant distributions were used to construct ratio of
ratios distributions. The protocol was approved by the Loughborough University ethics
committee. The statistical analysis shown in Figure 6, indicates an even distribution of
dynamic signal strength in the range of 120°–240° and suggests a tendency for stronger
signals in the range of 180° ± 40°.
3.3. Perfusion Mapping using Imaging Photoplethysmography
For the iPPG system shown in Figure 7, the camera (Mikrotron GmbH MC1311) has a
maximum resolution of 1280 × 1024 pixels and uses a 1.25“ CMOS sensor with square
518 Opto-Physiological Modeling Applied to Photoplethysmographic 
Cardiovascular Assessment
Motor mount
Camera
LED driver
triggerLED 1 LED 2
Finger CAM
Rotating platform
Light source pad
Finger mountFramegrabberPC
Finger/light source
mount
Rotating platform
Figure 4. Validation platform for Monte Carlo virtual environment. The rotating
platform (top) was powered by a stepper motor, programmed to rotate the
camera in 9° steps. The dual-wavelength LED light source was housed in
an ergonomic pad within the finger mount into which subjects inserted
their index finger (bottom-right) [52].
pixels measuring 12 µm. The pixels are encoded using 10 bits, making the imaging sensor
capable of detecting the weak arterial pulsation. A custom built dual-wavelength LED ring
light source (λ1: 650 nm, λ2: 870 nm) with a parabolic reflector (DIA: 18 cm, O.L:
6.5 cm, B&Q, UK) was mounted around the camera zoom lens (Computar, Japan) to
provide a collimated and uniform illumination on a plane perpendicular to the axis of the
lens [64]. The ring light consisted of 20 LEDs: 10 with a peak wavelength of 650 nm
(TRC650SMD0603, WelTek Co. Ltd., Taiwan), each emitting 1.0 mW power at a forward
current of 20 mA, and another 10 with a peak wavelength of 870 nm (TRC870SMD0603,
WelTek Co. Ltd., Taiwan) emitting 1.3 mW power individually. The arrangement of the
LEDs is shown in the right inset of Figure 7. A control circuit with a microcontroller
(PIC16F876A, MicroChip Inc., USA) alternately powered each wavelength group of
LEDs such that the light output duration for each wavelength was constant. The relative
illumination timings are illustrated in the left insets of Figure 7, where the camera was
triggered every time there was a switch of wavelength. The frame rate was set at 30 fps (15
fps for each wavelength), which was sufficient to recover the shape of the PPG arterial
Journal of Healthcare Engineering · Vol. 4 · No. 4 · 2013 519
90 108 126 144 162 180 198 216 234 252 270
0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
Circumferential position (deg)
Am
pl
itu
de
 (a
.u.
)
 
DC & ratio distributions
 
 
 
DC IR
DC red
AC/DC IR
AC/DC red
Ratio of Ratios
Figure 5. DC and DC normalized peak-to-peak AC distributions from 12 bit
camera data sweep with window of size 6 × 6 pixels, and light source at
0 deg [52]. From each signal, the Quasi-DC component (dotted curve)
was extracted by low-pass filtering, and the AC component was extracted
by taking the difference between detected peak and trough envelopes.
Quasi-DC and AC components were then used to generate corresponding
AC/DC and ratio of ratios components (solid curves). Each point of the
above distributions corresponds to the mean of the corresponding signal
component.
520 Opto-Physiological Modeling Applied to Photoplethysmographic 
Cardiovascular Assessment
 
90 135 180 225 270
2
4
6
8
10
In
te
ns
ity
 (a
.u.
)
Circumferential position (deg)
AC/DC distributions - Infrared
90 135 180 225 270
0
2
4
6
8
In
te
ns
ity
 (a
.u.
)  
Circumferential position (deg)
AC/DC distributions - Red
90 108 126 144 162 180 198 216 234 252 270
0
0.5
1.0
1.5
2.0
In
te
ns
ity
 (a
.u.
)
Circumferential position (deg)
Ratio of ratios distributions - 10 subjects
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channels (right), and ratio of ratios distributions (bottom) for a 10 subject
study [52].
waveforms. We observed arbitrary areas of the skin surface, from a few square millimeters
to several square centimeters. The camera was mounted on an optical bench with the lens
positioned approximately 13 cm away from the palm of the subject (Figure 5). The
protocol was approved by the Loughborough University ethnics committee.
The spatial resolution of the 2-D and layered perfusion map is determined by the size
of the ROI, which is affected by the resolution of the captured frame, the quality of the
iPPG signal and the tissue’s spatial point spread function. The optical resolution for the
C-mount zoom lens with the CMOS camera was calculated as 1.0 × 1.0 µm2 of 650 nm
illumination and 1.5 × 1.5 µm2 of 870 nm which are much smaller than the pixel size
12 × 12 µm2 of the CMOS camera. Given the uniform illumination and the homogenous
tissue model, the mean path length L(AC) for all layers remains constant as long as ROI
size is above the optical spatial resolution of the deepest layer, 15.32 mm,
corresponding to the size of ROI 100 × 100 pixels2. Thus the resolution of the captured
frame is mainly determined by the pixel size of the camera.
By employing the principles relating to PPG, blood perfusion maps were generated
from the power of the PPG signals in the frequency domain. The acquired image frames
were processed as follows:
(1) Ten seconds worth of image data were recorded with the acquisition system.
(2) The average fundamental frequency of the PPG signal was manually extracted
(1.4 Hz).
(3) The pixel values of all images were extracted for a particular pixel position to
form a pixel value vector in the time domain.
(4) The 64-point Fast Fourier Transform (FFT) was calculated for the signal at the
pixel position.
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Figure 7. Illustration of iPPG system. The depicting illumination and imaging
geometry (right); the relative timing signals (top); and the LED
arrangement of the dual-wavelength ring light (bottom) [64]. Reproduced
with permission.
(5) The Power of the FFT tap corresponding to the PPG fundamental frequency was
copied into the same pixel coordinates of a map of overall blood perfusion.
Repeating procedures (3) to (5) for all the remaining pixels (clusters) provides a new
matrix (image) whose elements (pixels) depend on the power of the detected blood
volume variation. This technique allows the generation of a blood perfusion map, as a
high PPG power can be attributed to high blood volume variation and ultimately to
blood perfusion.
PPG information such as heart rate is clearly observed from one wavelength in Figure
8 (left). The time-frequency representation of the pulsatile components derived from
iPPG signals is presented for a time window of 10 seconds (150 frames) in Figure 8
(right). The fundamental frequency (i.e., HR frequency) and 1st harmonic can be
identified in Figure 8 (right), indicating that both the HR and the shape of the
plethysmogram were determined.
The iPPG signal can be quantitatively related to the optical properties of each layer.
The conversion of a 2-D map to a 3-D perfusion map is performed by applying the opto-
physiological model at each ROI on the 2-D map, where the model allows for the
determination of the relative contributions of different layers to the ROI-dependent
perfusion of the 2-D surface map. By mapping the layered components of each ROI, it
is possible to illustrate the relationship between segmented AC and DC signals, and the
relationship between segmented and whole iPPG signals. Figure 9 shows the segmented
perfusion from a hand under 870 nm illumination, normalized with respect to the DC
intensities, and plotted in a 3-D format to illustrate the layered dynamic blood
perfusion.
The iPPG signal is quantitatively related to the optical properties of each layer. The
layered perfusion mapping illustrates the relationship between segmented AC and DC
signals, and the relationship between segmented signal and the total iPPG signal.
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corresponding joint time-frequency diagram of the AC component of
10 sec duration, computed using pseudo Wigner-Ville distribution (right).
4. DISCUSSION
High correlation is apparent between corresponding distributions at different
wavelengths, thereby suggesting that the two light sources are trans-illuminating the
same body of tissue at each circumferential position. A smoother response from red
illumination is apparent, as would be expected from a higher degree of optical diffusion.
This is substantiated by the fact that the scattering coefficients of all relevant human
tissue types under red illumination are notably higher than those corresponding to IR.
Ratio of ratios distribution shows a high variability of ± 0.3 in the central positions.
Also, an offset is visible between both static and dynamic responses with respect to
illumination wavelength. This is evidence of variations in light source and finger
positions due to individual recording sessions for each wavelength.
In order to obtain quality PPG signals, the uniform illumination on the skin surface
of the subject seemed vital to capture pulsatile waveforms from the ROI. Hence the
distance between the cameras coupled the illumination sources (650 nm and 870 nm)
and the subject was maintained at 20-30 cm away. The perfusion map in Figure 9 is
normalized with respect to DC intensities, thereby providing a visual representation
of signal quality with respect to position on the skin surface. As the perfusion map is
layered, it also illustrates the relationship between segmented signals and the total
iPPG signals. The spatial resolution of the 2-D and layered perfusion mapping is
determined by the size of ROI, which is affected by the resolution of the captured
frame, the quality of the iPPG signal and the tissue’s spatial point spread function.
Through the perfusion mapping, the iPPG signal is quantitatively related to the
segment optical properties of each layer. By mapping the layered components of
AC/DC ratio of each ROI, all the points within layered tissue’s spatial point spread
function in Figure 9 contribute to the ROI-dependent AC/DC ratio. The perfusion
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Figure 9. Segmented perfusion mapping of the multi-layer skin tissue of palm
under 870 nm illumination, generated using eqns. 9 and 10 on the PPG
signals derived from each pixel position of the images acquired from the
iPPG setup [64]. The y dimension runs from the base of the palm to the
base of the fingers; the x dimension runs across the palm from left to
right; the depth coordinate of the top of each layer is shown.
map indicates that the deep dermis layers are the main contributor to blood perfusion
up to 80% of the total perfusion, a result in accordance with simulation setup and
empirical value. As the top two layers contain no pulsatile blood, there is no blood
perfusion. The deeper dermal structures contain the arterioles, venules, and shunting
vessels to feed and drain the capillary network and aim at maintaining an adequate
body temperature [68]. As the top two layers contain no pulsatile blood, there is a
negligible blood perfusion. Based upon the current model and simulation settings, the
geometry of individual layers of tissue is static and identical, and the normalized
layered power mapping can mainly provide information about the dynamic optical
properties of tissue. Main issues limiting the accuracy of the current approach are the
motion artefact and the uncertainty of the degree of correspondence between this
model and the real tissue.
There is an expected variation between the model predictions and the in vivo
experimental outputs due to the difficulty to quantify surface reflection and the
sensitivity of the current approach based upon a predefined tissue structure. As the
parameters of the predefined tissue approach real life, an increasing correlation is
expected between the outputs of the opto-physiological model and empirical
measurements. This research would greatly benefit from a close-to-real tissue structure
with accurate measurement of the internal makeup of the tissue bed.
In all the above experiments, acquisition of real data, generation of simulated data,
and post-analysis of data were performed in separate stages. The volume of data
produced, particularly from the image acquisition and simulation platforms, poses a
significant challenge when working towards a real-time system. Some work has been
done towards developing a scalable system that acquires images, processes the image
data, and outputs physiological information in real-time [69].
In a clinical setting, physiological assessment relies on the real-time execution of
signal processing codes as a key to enabling safe, accurate and timely decision-making,
allowing clinicians to make important decisions and to perform medical interventions
based on hard facts that are derived in real-time from physiological data [65, 66]. This
is an area where advanced computer architecture concepts, routinely utilized in high-
performance consumer and telecoms Systems-on-Chip (SoC) [67], can potentially
provide the required data streaming and execution bandwidth to allow for the real-time
use of the opto-physiological models presented in this paper. These models would
otherwise be used off-line (in batch mode) using more established techniques and
platforms (e.g., sequential execution on a PC host).
5. CONCLUSION
On-going progress is being made in a multitude of areas concerning
photoplethysmographic cardiovascular assessment. Significant paradigm shifts in
photoplethysmographic measurement techniques can be categorized into two themes,
namely the migration from point (1D) to image (2D) sensing, and the migration from
contact to non-contact sensing. This paper reviews a body of research comprising two
OP models that have led to significant progress in the design of point and imaging
sensors for the acquisition and interpretation of cardiovascular performance.
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The Monte Carlo validation approach to OP modeling relies on a process of fine-
tuning the accuracy of characterization for both simulation and empirical validation.
The approach demonstrates its functionality at a qualitative level and provides a path
towards increasingly comprehensive descriptions of the mechanisms involved not only
in point measurement, i.e. pulse oximetry, but also in the layered perfusion mapping,
i.e. iPPG. In the present OP models, the changes of µa and µs can be related to the
dynamic change, and this means the dynamic part of the OP model can be validated
through in vitro phantom validation. The precision validation of the dynamic
component can also be achieved by using a phantom with an artificial vessel network
pumped with a blood substitute.
The use of iPPG proves extremely useful for the study of OP models, thanks to
the breadth of empirical data it provides, particularly in comparison to point
measurement techniques. OP modeling research and its application in PPG bring
insights into the physiological phenomena that can be reflected as changes in tissue
optical properties and could therefore provide characterization of cardiovascular
status. With this approach, effective cardiovascular assessment techniques could be
further developed through a better understanding of OP principles and an
increasingly informed design of sensing probes for point measurement and non-
contact imaging.
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